Title
Ask for a clear lorlatinib funding decision in New Zealand
58 / 80 charactersDENIS · “DENK” TO HIS MATES
This draft asks for a transparent national response, rather than asking MPs to decide Denis’s treatment or promise a particular Pharmac decision.
Ask for a clear lorlatinib funding decision in New Zealand
58 / 80 charactersThat the House urge the Government to ask Pharmac to publish a clear update on lorlatinib funding for eligible people with ALK-positive advanced non-small cell lung cancer, including any supplier application, evidence still required, and the next steps and expected timeframe for assessment.
291 / 300 charactersPeople with ALK-positive advanced lung cancer and their whānau need reliable information about access to lorlatinib in Aotearoa. Individual clinical decisions belong with patients and their clinicians, and funding decisions belong with Pharmac. A clear update on the supplier application, evidence requirements and assessment pathway would help families understand what happens next and how lived experience can be heard.
421 / 500 charactersStart at the official Parliament petitions page
Petition guidance and character limits: New Zealand Parliament, checked 1 October 2026. Parliament’s moderation determines whether the final petition is in order.